Clinical trials
Phase 1 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
620 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 14 |
| 2003 | 6 |
| 2004 | 9 |
| 2005 | 15 |
| 2006 | 10 |
| 2007 | 14 |
| 2008 | 18 |
| 2009 | 17 |
| 2010 | 27 |
| 2011 | 24 |
| 2012 | 16 |
| 2013 | 23 |
| 2014 | 27 |
| 2015 | 17 |
| 2016 | 33 |
| 2017 | 21 |
| 2018 | 39 |
| 2019 | 24 |
| 2020 | 33 |
| 2021 | 25 |
| 2022 | 43 |
| 2023 | 34 |
| 2024 | 21 |
| 2025 | 34 |
| 2026 | 31 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 303 |
| Terminated | 88 |
| Recruiting | 79 |
| Active, not recruiting | 60 |
| Unknown status | 43 |
| Withdrawn | 26 |
| Not yet recruiting | 17 |
| Suspended | 2 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 43 |
| City of Hope Medical Center | 20 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 |
| M.D. Anderson Cancer Center | 15 |
| Duke University | 14 |
| Case Comprehensive Cancer Center | 10 |
| Novartis Pharmaceuticals | 10 |
| Jonsson Comprehensive Cancer Center | 9 |
| Nader Sanai | 9 |
| Mayo Clinic | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 620 |
| Glioma | 213 |
| Brain Neoplasms | 190 |
| Astrocytoma | 179 |
| Gliosarcoma | 171 |
| Oligodendroglioma | 115 |
| Central Nervous System Neoplasms | 81 |
| Ependymoma | 56 |
| Neoplasms | 41 |
| Medulloblastoma | 36 |
Trials
Showing 1 to 25 of 620. Each trial links to its page on Pharma Observatory.
520 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.